Literature DB >> 18162233

Mouse models of bone marrow transplantation.

Pavan Reddy1, Robert Negrin, Geoffrey R Hill.   

Abstract

Over the last 50 years, mouse models of bone marrow transplantation have provided the critical links between graft-versus-host disease (GVHD) and graft-versus-leukemia (GVL) pathophysiology and clinical practice. The initial insight from mouse models that GVHD and GVL were T cell dependent has long been confirmed clinically. More recent translations from mouse models have included the important role of inflammatory cytokines in GVHD. Newly developed concepts relating to the ability of antigen presenting cell (APC) and T cell subsets to mediate GVHD now promise significant clinical advances. The ability to use knockout and transgenic approaches to dissect mechanisms of GVHD and GVL mean that mouse systems will continue as the predominant preclinical platform. The basic transplant approach in these models, coupled with modern "real-time" immunologic imaging of GVHD and GVL is discussed.

Entities:  

Mesh:

Year:  2008        PMID: 18162233      PMCID: PMC2880470          DOI: 10.1016/j.bbmt.2007.10.021

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN: 1083-8791            Impact factor:   5.742


  57 in total

1.  Cytological identification of radiation-chimaeras.

Authors:  C E FORD; J L HAMERTON; D W BARNES; J F LOUTIT
Journal:  Nature       Date:  1956-03-10       Impact factor: 49.962

2.  Sialoadenitis in experimental graft-versus-host disease. An animal model of Sjögren's syndrome.

Authors:  K Fujiwara; N Sakaguchi; T Watanabe
Journal:  Lab Invest       Date:  1991-12       Impact factor: 5.662

Review 3.  Shared biology of GVHD and GVT effects: potential methods of separation.

Authors:  Daniel H Fowler
Journal:  Crit Rev Oncol Hematol       Date:  2005-10-03       Impact factor: 6.312

Review 4.  The primacy of the gastrointestinal tract as a target organ of acute graft-versus-host disease: rationale for the use of cytokine shields in allogeneic bone marrow transplantation.

Authors:  G R Hill; J L Ferrara
Journal:  Blood       Date:  2000-05-01       Impact factor: 22.113

5.  Transient graft-versus-host reaction in the treatment of leukemia in mice.

Authors:  M Boranić
Journal:  J Natl Cancer Inst       Date:  1968-08       Impact factor: 13.506

6.  Distinct roles for donor- and host-derived antigen-presenting cells and costimulatory molecules in murine chronic graft-versus-host disease: requirements depend on target organ.

Authors:  Britt E Anderson; Jennifer M McNiff; Dhanpat Jain; Bruce R Blazar; Warren D Shlomchik; Mark J Shlomchik
Journal:  Blood       Date:  2004-11-02       Impact factor: 22.113

7.  Chronic graft-versus-host disease after granulocyte colony-stimulating factor-mobilized allogeneic stem cell transplantation: the role of donor T-cell dose and differentiation.

Authors:  Kelli P A MacDonald; Vanessa Rowe; Cheryl Filippich; Diana Johnson; Edward S Morris; Andrew D Clouston; James L M Ferrara; Geoffrey R Hill
Journal:  Biol Blood Marrow Transplant       Date:  2004-06       Impact factor: 5.742

8.  Mast cell "disappearance" in chronic murine graft-vs-host disease (GVHD)-ultrastructural demonstration of "phantom mast cells".

Authors:  H N Claman; K L Choi; W Sujansky; A E Vatter
Journal:  J Immunol       Date:  1986-09-15       Impact factor: 5.422

9.  Clonal analysis of murine graft-vs-host disease. II. Leukokines that stimulate fibroblast proliferation and collagen synthesis in graft-vs. host disease.

Authors:  Y DeClerck; V Draper; R Parkman
Journal:  J Immunol       Date:  1986-05-15       Impact factor: 5.422

10.  Revealing lymphoma growth and the efficacy of immune cell therapies using in vivo bioluminescence imaging.

Authors:  Matthias Edinger; Yu-An Cao; Michael R Verneris; Michael H Bachmann; Christopher H Contag; Robert S Negrin
Journal:  Blood       Date:  2002-09-26       Impact factor: 22.113

View more
  52 in total

1.  Regulation of acute graft-versus-host disease by microRNA-155.

Authors:  Parvathi Ranganathan; Catherine E A Heaphy; Stefan Costinean; Nicole Stauffer; Caroline Na; Mehdi Hamadani; Ramasamy Santhanam; Charlene Mao; Patricia A Taylor; Sukhinder Sandhu; Gang He; Arwa Shana'ah; Gerard J Nuovo; Alessandro Lagana; Luciano Cascione; Susanna Obad; Oliver Broom; Sakari Kauppinen; John C Byrd; Michael Caligiuri; Danilo Perrotti; Gregg A Hadley; Guido Marcucci; Steven M Devine; Bruce R Blazar; Carlo M Croce; Ramiro Garzon
Journal:  Blood       Date:  2012-03-09       Impact factor: 22.113

2.  Interleukin-6 modulates graft-versus-host responses after experimental allogeneic bone marrow transplantation.

Authors:  Isao Tawara; Motoko Koyama; Chen Liu; Tomomi Toubai; Dafydd Thomas; Rebecca Evers; Peter Chockley; Evelyn Nieves; Yaping Sun; Kathleen P Lowler; Chelsea Malter; Norihiro Nishimoto; Geoffrey R Hill; Pavan Reddy
Journal:  Clin Cancer Res       Date:  2010-11-03       Impact factor: 12.531

3.  GM-CSF and IL-4 Fusion Cytokine Induces B Cell-Dependent Hematopoietic Regeneration.

Authors:  Jiusheng Deng; Yanqiu Li; Andrea Pennati; Shala Yuan; Jian Hui Wu; Edmund K Waller; Jacques Galipeau
Journal:  Mol Ther       Date:  2017-02-01       Impact factor: 11.454

4.  Absence of CD155 aggravates acute graft-versus-host disease.

Authors:  Sebastian Seth; Inga Ravens; Chun-Wei Lee; Silke Glage; Andre Bleich; Reinhold Förster; Günter Bernhardt; Christian Koenecke
Journal:  Proc Natl Acad Sci U S A       Date:  2011-02-14       Impact factor: 11.205

5.  Activated MHC-mismatched T helper-1 lymphocyte infusion enhances GvL with limited GvHD.

Authors:  Y Zeng; J Stokes; S Hahn; E Hoffman; E Katsanis
Journal:  Bone Marrow Transplant       Date:  2014-04-28       Impact factor: 5.483

6.  MicroRNA-155 Modulates Acute Graft-versus-Host Disease by Impacting T Cell Expansion, Migration, and Effector Function.

Authors:  Nina C Zitzer; Katiri Snyder; Xiamoei Meng; Patricia A Taylor; Yvonne A Efebera; Steven M Devine; Bruce R Blazar; Ramiro Garzon; Parvathi Ranganathan
Journal:  J Immunol       Date:  2018-05-02       Impact factor: 5.422

Review 7.  Mouse models in bone marrow transplantation and adoptive cellular therapy.

Authors:  Caroline Arber; Malcolm K Brenner; Pavan Reddy
Journal:  Semin Hematol       Date:  2013-06-11       Impact factor: 3.851

8.  Allogeneic T cell responses are regulated by a specific miRNA-mRNA network.

Authors:  Yaping Sun; Isao Tawara; Meng Zhao; Zhaohui S Qin; Tomomi Toubai; Nathan Mathewson; Hiroya Tamaki; Evelyn Nieves; Arul M Chinnaiyan; Pavan Reddy
Journal:  J Clin Invest       Date:  2013-11       Impact factor: 14.808

Review 9.  Regenerative stromal cell therapy in allogeneic hematopoietic stem cell transplantation: current impact and future directions.

Authors:  Jeffery J Auletta; Kenneth R Cooke; Luis A Solchaga; Robert J Deans; Wouter van't Hof
Journal:  Biol Blood Marrow Transplant       Date:  2009-12-16       Impact factor: 5.742

10.  Host-derived CD8+ dendritic cells are required for induction of optimal graft-versus-tumor responses after experimental allogeneic bone marrow transplantation.

Authors:  Tomomi Toubai; Yaping Sun; Gary Luker; Jun Liu; Kathryn E Luker; Isao Tawara; Rebecca Evers; Chen Liu; Nathan Mathewson; Chelsea Malter; Evelyn Nieves; Sung Choi; Kenneth M Murphy; Pavan Reddy
Journal:  Blood       Date:  2013-03-21       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.